Alkermes and Janssen enter arbitration over nanocrystal tech

21-04-2022

Alex Baldwin

Alkermes and Janssen enter arbitration over nanocrystal tech

T. Schneider / Shutterstock.com

Irish biopharmaceutical company Alkermes has entered arbitration proceedings over two license agreements with Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals.


Alkermes, Janssen Pharmaceuticals, license agreement, nanocrystal

LSIPR